GT Biopharma (GTBP) Accounts Payables (2010 - 2026)
GT Biopharma's Accounts Payables came in at $253,000 for Q1 2026, down 89.4% from $2.38 million a year earlier and down 66.2% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Accounts Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, GT Biopharma's Accounts Payables was $748,000, down 80.6% from FY2024.
- Accounts Payables carries a five-year compound annual growth rate of -19.7% (FY2020 to FY2025).
- Going back by year, Accounts Payables was $3.85 million in FY2024 (-11.0%), $4.33 million in FY2023 (+37.8%), $3.14 million in FY2022 (-61.7%) and $8.19 million in FY2021 (+265.1%).
- The Q1 2026 figure represents the lowest quarterly Accounts Payables in data going back to Q4 2010.
- Year-over-year, Accounts Payables has declined for three consecutive quarters, with an average decline of 51.9% over the last six quarters.
- The fastest year-over-year change in Accounts Payables over five years came in Q2 2022 (growth of 385.2%), and the weakest in Q1 2026 (a decline of 89.4%).
- Business Quant data shows GTBP's Accounts Payables at $748,000 (Q4 2025), $769,000 (Q3 2025) and $1.37 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | GT Biopharma | 9.11 Mn | 9.11 Mn | - | 253,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 253,000.00 |
| Dec 31, 2025 | 748,000.00 |
| Sep 30, 2025 | 769,000.00 |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Dec 31, 2024 | 3.85 Mn |
| Sep 30, 2024 | 2.61 Mn |
| Mar 31, 2024 | 3.21 Mn |
| Dec 31, 2023 | 4.33 Mn |
| Sep 30, 2023 | 3.97 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 3.13 Mn |
| Dec 31, 2022 | 3.14 Mn |
| Sep 30, 2022 | 3.33 Mn |
| Jun 30, 2022 | 7.26 Mn |
| Mar 31, 2022 | 8.11 Mn |
| Dec 31, 2021 | 8.19 Mn |
| Sep 30, 2021 | 2.80 Mn |
| Jun 30, 2021 | 1.50 Mn |
| Mar 31, 2021 | 2.38 Mn |
API Access
GT Biopharma Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();